Dawnrays Pharmaceutical (Holdings) Yönetim
Yönetim kriter kontrolleri 2/4
Şu anda CEO hakkında yeterli bilgiye sahip değiliz.
Anahtar bilgiler
Liwei Yu
İcra Kurulu Başkanı
n/a
Toplam tazminat
| CEO maaş yüzdesi | n/a |
| CEO görev süresi | less than a year |
| CEO sahipliği | n/a |
| Yönetim ortalama görev süresi | 18.2yrs |
| Yönetim Kurulu ortalama görev süresi | 16.5yrs |
Son yönetim güncellemeleri
Recent updates
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Earnings Might Not Be As Promising As They Seem
Sep 21
Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015
Sep 11Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.065
May 25Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.065
Apr 22Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.065
Apr 08Dawnrays Pharmaceutical (Holdings) (HKG:2348) Is Due To Pay A Dividend Of CN¥0.065
Mar 25Dawnrays Pharmaceutical (Holdings) (HKG:2348) Has Announced A Dividend Of CN¥0.015
Aug 30Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Shareholders Will Receive A Bigger Dividend Than Last Year
May 26Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of CN¥0.073
Apr 04Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be CN¥0.015
Sep 19Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Solid Profits Have Weak Fundamentals
Sep 22Dawnrays Pharmaceutical (Holdings) (HKG:2348) Will Pay A Dividend Of HK$0.015
Sep 12Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Dividend Will Be HK$0.015
Aug 29Here's How We Evaluate Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Dividend
Feb 28Would Shareholders Who Purchased Dawnrays Pharmaceutical (Holdings)'s (HKG:2348) Stock Five Years Be Happy With The Share price Today?
Feb 07
Yung Lai Hung Is The Co-Founder & Executive Director of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) And They Just Picked Up 34% More Shares
Jan 14Dawnrays Pharmaceutical (Holdings) Limited's (HKG:2348) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Dec 22What Kind Of Investors Own Most Of Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)?
Dec 09Three Things You Should Check Before Buying Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348) For Its Dividend
Nov 23CEO
Liwei Yu (54 yo)
less than a year
Görev süresi
Ms. Liwei Yu is Chief Executive Officer of Dawnrays Pharmaceutical (Holdings) Limited from September 13, 2024. Ms. Yu is the Chief Human Resources Officer of the Group and fully responsible for the human r...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 22.1yrs | CN¥1.05m | 7.15% HK$ 132.1m | |
| Co-Founder & Executive Director | 29.8yrs | CN¥672.00k | 0.13% HK$ 2.3m | |
| Chief Executive Officer | less than a year | Veri yok | Veri yok | |
| Chief Financial Officer | 6.6yrs | Veri yok | Veri yok | |
| Company Secretary | no data | Veri yok | Veri yok |
18.2yrs
Ortalama Görev Süresi
60yo
Ortalama Yaş
Deneyimli Yönetim: 2348 'un yönetim ekibi deneyimli ve deneyimlidir ( 18.2 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 22.1yrs | CN¥1.05m | 7.15% HK$ 132.1m | |
| Co-Founder & Executive Director | 22.1yrs | CN¥672.00k | 0.13% HK$ 2.3m | |
| Independent Non-Executive Director | 9.4yrs | CN¥326.00k | Veri yok | |
| Non-Executive Director | 19yrs | CN¥271.00k | Veri yok | |
| Independent Non-Executive Director | 14.1yrs | CN¥326.00k | Veri yok | |
| Independent Non-Executive Director | 6.5yrs | CN¥326.00k | Veri yok |
16.5yrs
Ortalama Görev Süresi
60.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: 2348 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 16.5 yıldır).